Cargando…

HIV replication and evolution in patients on highly active antiretroviral therapy

Detalles Bibliográficos
Autor principal:	Siliciano, Robert F
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716918/ http://dx.doi.org/10.1186/1742-4690-3-S1-S11

Ejemplares similares

Modest deviations from optimal adherence to antiretroviral therapy promote residual HIV-1 replication in the absence of virological rebound in plasma
por: Pasternak, Alexander O, et al.
Publicado: (2011)

International perspectives on adherence and resistance to HIV antiretroviral therapy
por: Bangsberg, D
Publicado: (2010)

Immune-based therapy using gamma interferon ingaron in the treatment of HIV/AIDS patients with active pulmonary tuberculosis (PTB) not previously highly active antiretroviral therapy (HAART)
por: Yola, Auwal, et al.
Publicado: (2006)

A phase 1/PK study of Sunitinib with highly active antiretroviral therapy (HAART) in HIV+ patients with solid tumors: AIDS malignancy consortium study 061
por: Deeken, John F, et al.
Publicado: (2012)

Antiretroviral drug resistance and viral tropism in HIV-1 CRF06_cpx infected patients failing antiretroviral (ARV) therapy
por: Pauskar, Merit, et al.
Publicado: (2014)

AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy
por: Nguyen, HQ, et al.
Publicado: (2009)

Metabolic syndrome, insulin resistance and the risk of cardiovascular disease in HIV patients undergoing antiretroviral therapy
por: Tilişcan, Cătălin, et al.
Publicado: (2013)

Correlation between inflammatory biomarkers and metabolic disorders in HIV infected patients undergoing antiretroviral therapy
por: Mihăilescu, Raluca, et al.
Publicado: (2013)

Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
por: Bourry, Olivier, et al.
Publicado: (2009)

Long-term probability of detecting drug-resistant HIV in patients starting antiretroviral therapy within the first year of HIV infection
por: Lodi, S, et al.
Publicado: (2010)

Leptin dysfunction and the risk of dyslipidemia and metabolic syndrome in Romanian HIV-infected patients undergoing antiretroviral therapy
por: Tilişcan, Cătălin, et al.
Publicado: (2014)

Antiretroviral dynamics determines HIV evolution and predicts therapy outcome
por: Rosenbloom, Daniel I. S., et al.
Publicado: (2012)

Autologous T-cell therapy based on a lentiviral vector expressing long antisense RNA targeted against HIV-1 env gene influences HIV replication and evolution in vivo
por: Pasternak, Alexander, et al.
Publicado: (2013)

Patients’ expectations versus doctors’ expectations in antiretroviral therapy
por: Largu, Alexandra Maria, et al.
Publicado: (2014)

OA031-03. Increased regulatory T cell frequency and HIV-1 specific suppression after therapeutic vaccination of HIV-infected patients on antiretroviral therapy
por: Macatangay, BC, et al.
Publicado: (2009)

Mitochondrial ageing and antiretroviral therapy exposure
por: Payne, BAI, et al.
Publicado: (2010)

Antiretroviral treatment and association with prematurity in perinatal HIV-exposed children
por: Tudor, Ana Maria, et al.
Publicado: (2014)

HIV-1 integrase SUMOylation and viral replication
por: Zamborlini, Alessia, et al.
Publicado: (2011)

The challenges of managing antiretroviral treatment in children perinatally infected with HIV in Romania
por: Cibea, Alina, et al.
Publicado: (2014)

Factors associated with loss to follow up after entry into care of HIV infected children ineligible for antiretroviral therapy: data from an HIV cohort study in India
por: Naik, Praveen Kumar, et al.
Publicado: (2014)

Exploiting replication deficiencies to illuminate HIV: host interactions
por: Malim, Michael
Publicado: (2011)

Interplay between HIV-1 replication and RNAi effectors
por: Chable-Bessia, Christine, et al.
Publicado: (2009)

Antiretroviral treatment in adult ethnobotanical intravenous drug users recently infected with HIV
por: Popa, Ionuț Cristian, et al.
Publicado: (2014)

Impact of baseline HIV-1 tropism on viral response and CD4 gains in antiretroviral-naïve patients
por: Seclén, E, et al.
Publicado: (2010)

Adherence to antiretroviral treatment regimens and correlation with risk of hospitalization among commercially insured HIV patients in the US
por: Sax, PE, et al.
Publicado: (2010)

Evolution of progressive multifocal leukoencephalopathy in HIV-infected patients
por: Iancu, Ana Maria, et al.
Publicado: (2014)

M. tuberculosis enhances its virulence during replication in blood from HIV patients
por: Ryndak, Michelle B, et al.
Publicado: (2014)

Restrictions to HIV-1 replication in resting CD4(+) T lymphocytes
por: Fackler, Oliver
Publicado: (2013)

Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome
por: Lobodan, Alina, et al.
Publicado: (2014)

Potent suppression of HIV viral replication by a novel inhibitor of Tat
por: Mousseau, Guillaume, et al.
Publicado: (2012)

Evidence for replication of human endogenous retroviruses type-K (HERV-K) in HIV-1 positive patients
por: Contreras-Galindo, Rafael, et al.
Publicado: (2006)

LEDGF/p75 is critical but not essential for multiple-round HIV 1 replication
por: Schrijvers, RLG, et al.
Publicado: (2010)

Mother to child transmission (MTCT) of HIV - almost a thing of the past? A cohort study of HIV positive women starting antiretroviral drugs in pregnancy
por: Leonard, Hugh A, et al.
Publicado: (2014)

Immune activation, viral replication and mucosal depletion
por: Grossman, Zvi
Publicado: (2006)

Impact of transmitted CTL escape mutations on replicative capacity and HIV pathogenesis in early infection
por: Prince, J, et al.
Publicado: (2012)

Polymorphism in HIV-1 dependency factor PDE8A affects gene expression and HIV-1 replication in primary macrophages
por: Booiman, Thijs, et al.
Publicado: (2011)

Screening for new antiretroviral targets
por: Fassati, Ariberto
Publicado: (2013)

HIV low-level persistent viremia under new antiretroviral regimens: what we have learned up to this point?
por: Gheorghiță, Valeriu, et al.
Publicado: (2014)

A U5 repressor of reverse transcription is required for optimal HIV-1 infectivity and replication
por: Meredith, Luke, et al.
Publicado: (2009)

Partial inhibition of HIV replication by type-I interferons: impact of cell-to-cell viral transfer
por: Vendrame, Daniela, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_g3kl2mg2o4graq8t6uen4nlpfa